ICM
AVX

Invenomic Capital Management’s AVX Corporation AVX Stock Holding History

Invenomic Capital Management’s Portfolio AVX Stock Details AVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,166
Closed -$65K – 187
2019
Q4 		$65K Buy
+3,166
New +$54.5K 0.03% 114

Other funds holding AVX

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Invenomic Capital Management's AVX Position: Q1 2020 in Review

Invenomic Capital Management sold out of AVX Corporation (AVX) in Q1 2020, closing a stake of 3,166 shares — an estimated $65K sold.

Invenomic Capital Management first reported a position in AVX in Q4 2019 and held it in 1 quarter. The position peaked at $65K in Q4 2019. 10 funds tracked by Wall St. Rank hold AVX as of Q1 2020.

  • Invenomic Capital Management reported no remaining AVX Corporation position as of Q1 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 3,166 AVX Corporation shares in Q1 2020, an estimated $65K.
  • Invenomic Capital Management first reported a position in AVX Corporation in Q4 2019 and held it in 1 quarter.
  • Invenomic Capital Management's AVX Corporation position peaked at $65K in Q4 2019.
  • 10 funds tracked by Wall St. Rank held AVX Corporation as of Q1 2020.

Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.